Peking Union Medical College Hospital: Autoimmune Diseases trials
The registry lists 11 Autoimmune Diseases studies with Peking Union Medical College Hospital as lead sponsor. 3 are open to participants now and 0 have results posted.
Early Phase 1 1Phase 2 2No phase 8(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Observational Study of Pediatric Rheumatic and Immunologic Diseases in China: The CAPRID RegistryRecruitingNCT06417502
- Treatment Strategies for IgG4-RD Patients With Superficial Organ InvolvementRecruitingNCT05789030Not applicable
- Treatment Strategies for IgG4-RD Patients With Internal Organ InvolvementRecruitingNCT05789017Not applicable
- Treatment Strategies in IgG4-RD Patients With Re-elevation of Serum IgG4 Level During Maintenance Remission PeriodStatus unknownNCT05974683Not applicable
- Withdraw Drug in Stable IgG4-Related DiseaseStatus unknownNCT04124861Not applicable
- Diagnostic and Imaging Indicators of Immunocardiomyopathic PatientsStatus unknownNCT03885375
- Leflunomide Treatment for IgG4-RDStatus unknownNCT03715699Not applicable
- Continuous Glucose Monitoring on Patients With Active Autoimmune Diseases Following High-dose Predisone TreatmentCompletedNCT03018600
- Study of Treatment Response on IgG4 Related Disease (IgG4RD)Status unknownNCT02458196Phase 2
- Inhalation of Granulocyte-macrophage Colony-stimulating Factor (GM-CSF) for Autoimmune Pulmonary Alveolar Proteinosis (PAP)Status unknownNCT02243228Phase 2
- 18F-FDG PET/CT for IgG4-Related DiseaseStatus unknownNCT01665196Early Phase 1